483
Tran-Johnson, Tram K.FDA 483 - Tran-Johnson, Tram K. - February 01, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Ryan-Johnson, Tram K., a clinical investigator in San Diego, revealed two significant observations. The firm failed to report adverse effects related to an investigational drug to the sponsor, including severe orthostatic hypotension, syncope, and worsening drowsiness. Additionally, the firm failed to maintain adequate case histories, specifically by not transcribing a subject's history of suicide ideation into study records.
Open in Dashboard
ID · ca952b30-901d-4b54-839b-5a19437c030f